RE:The Indian Reuters Writer has a "history"SWYG, '
"While the trial did not, with this sample size, statistically achieve its primary end point target of absolute reduction in mortality at 28 days"
They did not meet their endpoint, which means failure for that aspect. She is correct in her assessment.
Now when they meet with the FDA, they will figure out where to go, There are positives but will another 'trial' be necessary or can they figure with the data they have now to conditionally approve this treatment for a specific population???